Latest Business and People News
Updated employee announcements, business news, awards, and recognition in the industry today.
People News
Saama Technologies, Inc., a big data and analytics solutions company, announced that Mehdi Benchoufi, M.D., Assistant Professor in the Clinical Epidemiology Center at Hôtel-Dieu Hospital, University Paris Descartes, has joined its Board of Advisors.
Bio-Optronics, the maker of the Clinical Conductor Clinical Trial Management System, announces the appointment of Sujay Jadhav to its Board of Directors.
LabConnect, LLC, a global provider of central laboratory and support services for biopharmaceutical, medical device, and CROs, announces the promotion of three executives to top-level management positions: Barry Simms, MBA, as Chief Operating Officer, Trenton Harris, MSM/MBA, as Executive Vice President and Elizabeth Koury, MS, as Vice President, scientific affairs.
Clinipace, a global full-service CRO, expands its leadership team by appointing Dawn Sauro as Chief Development Officer and Sharon Moore as Chief Medical Officer.
InClinica, a global clinical CRO, announced that Jeffrey Schwartz has been appointed Assistant Vice President of Business Development and Anthony J. Esposito, Jr. has been appointed Senior Director of Quality Assurance.
Business News
Veeva Systems, a cloud-based solutions provider, announced that 12 adapters including a top 20 pharmaceutical company and CROs are now using Veeva Vault EDC to improve data management in their clinical trials.
Novotech, an Asia-Pacific CRO, announced that it has signed Memorandum of Understandings with five medical institutions in the region.
Clinipace, a global full-service CRO, expands its leadership team and launches a new brand identity, CHALLENGE ACCEPTED, to support its future growth as a midsized CRO.
proinnovera GmbH, a full service CRO, announced the establishment of the Company’s wholly owned subsidiary, proinnovera Inc. in North Carolina.
Recognition
Certara, a drug development consultancy, served as a key member of the MDGH drug development team when they were granted FDA approval for moxidectin for river blindness.
Navitas Life Sciences, a full service Clinical, Regulatory & Safety solutions and services provider, announced that it has been recognized as a ‘Leader’ in the IDC MarketScape: Worldwide Life Science R&D BPO Services 2018 Vendor Assessment.
Merck Launches Phase III Trials of Once-Monthly Oral HIV PrEP Candidate MK-8527
July 14th 2025In the new EXPrESSIVE clinical trial program, Merck will evaluate MK-8527, a once-monthly, oral PrEP therapy, in populations at high risk of HIV-1 infection, including adolescent girls and women in sub-Saharan Africa.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Baxdrostat Shows Significant Blood Pressure Reduction in Phase III BaxHTN Trial
July 14th 2025In the BaxHTN Phase III study, AstraZeneca’s baxdrostat demonstrated statistically significant and clinically meaningful reductions in systolic blood pressure in patients with uncontrolled or treatment-resistant hypertension.
New FDA Initiative Reveals Common Reasons for Drug Application Rejection
July 11th 2025By publishing more than 200 complete response letters, the FDA is offering new visibility into the issues that most often delay drug approvals, including safety concerns, trial design flaws, and manufacturing gaps.
Arcus’ Quemliclustat Earns Orphan Drug Designation as Phase III Pancreatic Cancer Trial Advances
July 11th 2025The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the global PRISM-1 Phase III trial nears full enrollment following promising survival data from ARC-8.
